|
|
||||||||
J Biol Chem, Vol. 274, Issue 40, 28308-28313, October 1, 1999
From the Klinisches Institut für Herzinfarktforschung an der
Medizinischen Universitätsklinik Heidelberg, Bergheimerstraße
58, D-69115 Heidelberg, Germany
A polyclonal antiserum that recognizes residues
100-119 within the Heterotrimeric G proteins composed of The structural determinations for several members of the family of
heterotrimeric G proteins have shown that their A screening of different G Materials
The characteristics and sources of antibodies and
Gs-derived peptides used in the current experiments are
listed in Table I. Forskolin,
7 Methods
Subjects, Preparation of Fat Cells, and Fat Cell
Ghosts--
Experimental details have been described in detail
elsewhere (16). Briefly, adipose tissue was from nondiabetic subjects undergoing elective abdominal or cosmetic breast surgery. The specimens
were cut into small pieces, and fat cells were isolated in a
HEPES-buffered Krebs-Henseleit solution, pH 7.4, containing 20 mM HEPES, 10 mM NaHCO3, 5 mM glucose, 20 g/liter albumin, and 1 mg/ml collagenase
(CLS, Worthington). After 30 min, fat cells were washed and resuspended
in 10 volumes of an ice-cold lysing medium containing 20 mM
MES,1 pH 6.0, 2 mM MgCl2, 1 mM CaCl2, 5 mM KCl, and 100 mg/liter soybean trypsin inhibitor. Cell
lysis was completed by mechanical shaking, and fat cell ghosts were
collected by low speed centrifugation (1,000 × g,
4 °C, 20 min).
Receptor-mediated Modulation of NADPH-dependent
H2O2 Generation--
A two-step procedure was
used, as reported elsewhere (16). Plasma membranes from adipocytes were
first exposed to hormones and were then assayed for NADPH oxidase
activity. The activation step was carried out in 30 mM
MOPS, pH 7.5, containing 120 mM NaCl, 1.4 mM
CaCl2, 2.5 mM MgCl2, 10 mM NaHCO3, and 0.1% human albumin. Membranes
were first incubated with 5 nM insulin in absence or
presence of 5 µM isoproterenol for 5 min to allow
receptor occupation. Thereafter, 50 µM GTP
To assess the effects of G protein antibodies and peptides
corresponding their target sequences on NADPH-dependent
H2O2 generation, membranes were exposed to both
types of agents at 4 °C for 45 min, as indicated in the legends to
figures, and were then subjected to the two-step procedure described above.
Determination of Adenylyl Cyclase Activity--
Adenylyl cyclase
activity of human fat cell plasma membranes was determined in 30 mM Tris-HCl, pH 7.5, containing 1 mM ATP, 2.5 mM MgCl2, 0.5 mM EDTA, 0.5 mM 3-isobutyl-1-methylxanthine, 10 µM GTP, 10 mM creatine phosphate, 0.1 mg of creatine kinase, and 0.1%
bovine serum albumin in a final volume of 100 µl. Reactions were
initiated by addition of 5-8 µg of membrane protein and were continued for 15 min at 37 °C in the absence or presence of
isoproterenol, as indicated. Reactions were terminated by 100 µl of
ice-cold perchloric acid (5%). cAMP was determined by radioimmunoassay (Amersham Pharmacia Biotech) after neutralization. To assess the effect
of G Cholera Toxin Treatment--
For cholera toxin (CTX) labeling,
membranes (500 µg) were incubated for 45 min at 37 °C in 1 ml of
30 mM MOPS, pH 7.5, containing 2.5 mM
MgCl2, 1.4 mM CaCl2, 120 mM NaCl, 10 mM thymidine, 10 mM arginine, 10 µM GTP, 10 µM NAD, and 100 µg of cholera toxin A subunit. Membranes were washed and then
subjected to GTPase assay.
GTPase Activity--
GTP hydrolysis was determined essentially
as described by Jakobs and Aktories (20). Untreated or CTX-treated
membranes were preincubated (20 min, 4 °C) in 20 mM
Tris-HCl, pH 7.6, containing 2.5 mM MgCl2, 0.5 mM EDTA, and 100 µM
N-ethylmaleimide (NEM) to inactivate Gi. After
washing, NEM-treated membranes were exposed to antibody K-20 or the
peptide corresponding to its target sequence for 40 min at 0 °C, as
indicated. For determination of GTPase activity membranes (5-10 µg
of protein) were incubated in 0.1 ml Tris-HCl (20 mM, pH
7.6) containing 0.2 µM GTP, 0.5 mM ATP, 0.5 mM AMP(PNP), 2.5 mM Mg Cl2, 1 mM EDTA, 1 mM dithiothreitol, 5 mM
creatine phosphate, 0.025 mg of creatine kinase, and
[
Low affinity GTPase activity was determined by measuring the rate of
GTP hydrolysis at 50 mM GTP. Less than 16% of total GTP hydrolysis was due to low affinity GTPases under the conditions used.
K-20-induced Dissociation of Gs--
In contrast to
other G proteins, G Immunoprecipitation--
After treatment with K-20, membranes
were pelleted and solubilized in 1% Triton X-100 for 30 min at
0 °C. Gs was immunoprecipitated by COOH-terminal
anti-G
Proteins were separated by SDS-polyacrylamide gel electrophoresis and
transferred to Hybond polyvinylidene difluoride membranes. Western
blotting was performed using anti-G Antibody K-20 selectively precipitated G Fig. 1 shows that antibody K-20 was not
only capable of specifically recognizing G The latter observation suggested that K-20 may bind to and activate
Gs in a manner similar to activated heptahelical receptors. To corroborate this latter hypothesis, untreated and cholera
toxin-treated membranes were incubated with increasing concentrations
of K-20 and assayed for high affinity GTPase activity in the presence of NEM, which inactivates Gi (20). The antibody caused a
concentration-dependent increase in GTP hydrolysis, which
was abolished after treatment with cholera toxin (Fig.
2A). At a maximal
concentration (1:1,000), the antibody increased GTPase activity by
approximately one-third, which is similar to the extent of activation
seen in the presence of a maximal concentration of the
An Antibody Directed against Residues 100-119 within the
-Helical Domain of G
s Defines a Novel Contact Site
for
-Adrenergic Receptors*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helical domain of G
s
(K-20) caused a dissociation of Gs into its component
subunits and activated a cholera toxin-sensitive high affinity GTPase.
Consistently, the antibody mimicked the stimulatory effects of the
-adrenergic agonist, isoproterenol, on adenylyl cyclase, which is
mediated by G
s, and its inhibitory action on
NADPH-dependent H2O2 generation, a
G
-mediated response. A peptide corresponding to the target
sequence of K-20 not only neutralized the receptor-mimetic effects of
the antibody but inhibited the whole spectrum of isoproterenol action
as well, including its antagonistic effects on adenylyl cyclase and
NADPH-dependent H2O2 generation. By
contrast, COOH-terminal anti-G
s selectively inhibited
the stimulatory effect of isoproterenol on cAMP formation without
affecting its inhibitory effect on NADPH-dependent
H2O2 generation. The data are consistent with
the concept that
-adrenergic receptors interact with multiple sites
on G
s each playing a distinct role, and strongly suggest
that antibody K-20 defines a novel contact site for
-adrenergic
receptors that localizes to the
-helical domain and is essential for
eliciting the complete spectrum of
-adrenergic responses.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
- and 
-subunits
transduce signals from cell surface receptors to downstream effectors and regulate intracellular membrane transport events (1-6).
Interaction of ligand-occupied receptors with heterotrimeric G proteins
triggers the exchange of GTP for GDP on the
-subunit, leading to a
sequential release of G
-GTP and the stable 
-complex from the
receptor. The released G protein subunits are then able to interact
with distinct effector enzymes and ion channels. G protein activation is terminated by hydrolysis of GTP by the intrinsic GTPase activity of
the
-subunit, leading to reassociation of G
and G
. The cycle is then complete, and the heterotrimeric G protein is able to be
activated again.
-subunits are
composed of two domains (1-6). The core domain contains regions with
sequence similarity to other GTPases and has a structure very similar
to Ras and elongation factor Tu (1-6). The
-helical domain is
unique to
-subunits of heterotrimeric proteins and not present in
other GTPases. It is therefore tempting to assume that the latter
domain may be important for specific functions of heterotrimeric G
proteins that are not shared by other members of the GTPase
superfamily, such as coupling to heptahelical receptors. Surprisingly,
current modeling suggests that receptor-G protein coupling is
exclusively by the core domain of G
and segments of the
- and
-subunits, however (1-6). The function of the
-helical domain is
still under investigation. Evidence has been presented to suggest that
it may influence the spontaneous rate of GDP release (7), and it has
been proposed that it may function as a GTPase-activating protein (8),
or may be involved in effector regulation (9).
s antibodies for their
applicability in studying insulin receptor-NADPH oxidase coupling
revealed that one of the commercially available antibodies (K-20),
which recognizes residues 100-119 within the
-helical domain of
G
s, mimicked the effects of inhibitory ligands, such as
the
-adrenergic agonist isoproterenol, on
NADPH-dependent H2O2 generation
that are transduced by Gs. We therefore explored whether
the epitope recognized by K-20 may define a new contact site for
activated
-adrenergic receptors or be involved in an alternative
route of Gs activation that may be utilized for a
receptor-independent activation of Gs by intracellular
pseudoreceptors or accessory proteins, for example (10-15).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-deacetyl-7
-(
-(morpholino)butyryl)hydrochloride, was from
Research Biochemicals International and cholera toxin (A-subunit) from Calbiochem.
S was added.
After 20 min, ghosts were collected by centrifugation, washed, and then
resuspended in 30 mM MES, pH 5.8, containing 120 mM NaCl, 4 mM MgCl2, 1.2 mM KH2PO4, 1 mM
NaN3, 250 µM NADPH, and 10 µM
FAD for determination of NADPH-dependent
H2O2 generation.
s-derived peptides and antibody K-20 on adenylyl
cyclase activity, membranes were pretreated with the K-20 antibody or peptides, as described above.
-32P]GTP (0.1-0.2 µmol) at 37 °C for 10 min.
Reactions were terminated by addition of 25% (w/v) activated charcoal.
Release of 32Pi was determined by counting
aliquots of the supernatants for radioactivity.
s does not dissociate in the presence
of GTP
S alone under the conditions used in the present experiments
(17, 18). Plasma membranes were therefore suspended in activation
buffer containing 50 µM GTP
S, as described above, and
incubated in the absence or presence of various concentrations K-20 for
25 min at ambient temperature, as indicated in the legend to Fig.
1.
s (RM/1), which does not discriminate between
heterotrimeric and monomeric G
s (17, 18).
Immunoprecipitations were carried out in 10 mM Tris-HCl, ph
7.4, containing 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.5% Nonidet P-40, proteinase inhibitors (0.4 mM phenylmethylsulfonyl fluoride, 2 µM
leupeptin, 2 µM pepstatin, 1 unit/ml aprotinin), and
antibody RM/1 at a dilution of 1:80 and 50 µM GTP
S.
The samples (30 µg of membrane protein/100 µl of precipitation
buffer) were incubated overnight at 4 °C. The immune complexes were
captured with protein A-agarose beads (Amersham Pharmacia Biotech) and
washed three times with 1 ml of washing buffer (10 mM Tris,
pH 7.4, containing 1% Triton X-100, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, and the protease
inhibitors). The beads were boiled in SDS-sample buffer.
s (RM/1) and
anti-G
(SW/1 from NEN Life Science Products) antibodies. Bands were
visualized by chemiluminescence using the ECL kit from Amersham
Pharmacia Biotech and were quantified by densitometric analysis. The
amount of G
was normalized to the amount of G
s
immunoprecipitated for each condition.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
s; neither
G
i nor G
o was detectable after
precipitation of solubilized membrane proteins by K-20 (data not shown).
s but also
promoted dissociation of Gs into its component subunits in
the presence of GTP
S. Membranes were pretreated with different K-20
concentrations and monitored for dissociation of Gs by a
immunoblot technique utilizing antibody RM/1, which does not
discriminate between heterotrimeric and monomeric G
s
(17, 18). Fig. 1 demonstrates that the amount of G
recovered in RM/1
immunoprecipitates was selectively reduced in membranes that had been
pretreated with K-20 in the presence of 50 µM GTP
S. In
the absence of GTP
S, the antibody had no influence on the subunit
composition of Gs, indicating that K-20 caused a guanine nucleotide triphosphate-dependent dissociation of
Gs, which is characteristic for a receptor-mediated
activation (1-5).

View larger version (9K):
[in a new window]
Fig. 1.
An antibody directed against residues
100-119 within the
-helical domain of
G
s (K-20) causes dissociation of
Gs into its component subunits. Plasma membranes were
incubated in the presence of 50 µM GTP
S either alone,
or with antibody K-20 for 25 min. Thereafter, G
s was
immunoprecipitated using the polyclonal antibody RM/1, as described
under "Methods." The immunoprecipitates were resolved by
SDS-polyacrylamide gel electrophoresis and immunoblotted for
G
s and G
using the antibodies RM/1 and SW/1,
respectively. The amounts of G
s and the
coimmunoprecipitated G
were determined by densitometric analysis.
The amount of G
was normalized to the amount of G
s
immunoprecipitated for each condition. Results are the means ± S.E. of four independent experiments.
-adrenergic
agonist isoproterenol (Fig. 2B).

View larger version (15K):
[in a new window]
Fig. 2.
Antibody K-20 stimulates a cholera
toxin-sensitive high affinity GTPase in human fat cell plasma
membranes. A, untreated (
) and CTX-treated (
) plasma
membranes were exposed to various concentrations of K-20 for 1 h
at 4 °C, and then assayed for GTPase activity, as described under
"Methods." B, effect of increasing concentrations of
isoproterenol on GTPase activities in untreated (
) and CTX-treated
(
) membranes. Basal GTPase activity of untreated controls was
9.9 ± 1.1 pmol × mg
1 × min
1.
Values are means ± S.D. of seven separate experiments carried out
in triplicate. *, p < 0.01 (paired t
test).
Consistent with its stimulatory effects on GTP hydrolysis by
Gs, K-20 activated adenylyl cyclase activity in human fat
cell plasma membranes over the same range of concentrations that were effective in stimulating GTPase activity (Fig.
3A); the maximal effect of the
antibody was similar to that seen in the presence of isoproterenol
(16). Activation of adenylyl cyclase was not the sole
isoproterenol-like effect of K-20 (Fig. 3B). The antibody mimicked the inhibitory effect of the
-adrenergic agonist on NADPH-dependent H2O2 generation as
well, which is mediated by 
-subunits (16). At maximal
concentrations, both isoproterenol and K-20 inhibited the stimulatory
effect of insulin on NADPH-dependent H2O2 generation completely, and their effects
could be reversed by G
-antibodies or agents that specifically bind
G
2. Thus, K-20 mimicked the action of
activated
-adrenergic receptors in every aspect studied, suggesting
that the epitope recognized by K-20 may either define a new contact
site for
-adrenergic receptors on the
-helical domain of
Gs or be involved in an alternative route of Gs
activation that may be utilized for a receptor-independent activation
of Gs.
|
The stimulatory effect of K-20 on GTP hydrolysis could be neutralized
by a peptide corresponding to its target sequence, as expected (Fig.
4A). Surprisingly, the peptide
not only neutralized the effect of the antibody on GTPase activity but
inhibited isoproterenol action on GTP hydrolysis as well (Fig.
4B). At a concentration of 2.5 µM, the peptide
suppressed the stimulatory effect of isoproterenol over the whole range
of concentrations tested, suggesting that the epitope recognized by
K-20 may in fact be essential for interaction of activated
-adrenergic receptors with Gs (Fig. 4B).
|
Fig. 5 compares the effects of peptide
100-119 and of a COOH-terminal decapeptide derived from
G
s (Table I) on
isoproterenol-stimulated rates of cAMP formation and its inhibitory
effect on NADPH-dependent H2O2
generation. At the concentrations used, both peptides decreased isoproterenol induced cAMP production to basal levels (Fig.
5A). The inhibitory effect of isoproterenol on
NADPH-dependent H2O2 generation was
also reversed by peptide 100-119 (Fig. 5B). Surprisingly, the COOH-terminal decapeptide was only effective in inhibiting cAMP
formation, a G
s-mediated response, but failed to
influence the inhibitory effect of isoproterenol on
NADPH-dependent H2O2 generation,
which is mediated by 
-subunits (Fig. 5B). The effect of peptide 100-119 was specific, inasmuch as this fragment had no
effect on forskolin-stimulated rates of cAMP production (Fig. 6).
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
This report demonstrates that polyclonal antibodies directed
against a segment of the
-helical domain encompassing residues 100-119 of G
s caused a dissociation of Gs
into its component subunits, stimulated a cholera toxin-sensitive high
affinity GTPase, and were as efficient in stimulating adenylate cyclase
activity as the
-adrenergic agonist isoproterenol, suggesting that
this antibody binds to and stimulates Gs in manner similar
to that of ligand-occupied receptors. Consistently, the antibody not
only stimulated adenylate cyclase but mimicked the inhibitory action of
isoproterenol on NADPH-dependent
H2O2 generation as well, which is mediated by
G
, indicating that activation of a single G protein, Gs, can provide enough G
for eliciting a
G
-mediated response, which has been questioned (21). With one
possible exception (22), K-20 is the first example of an antibody
exhibiting receptor-mimetic effects, a property that should be
extremely useful in elucidating the role of Gs in processes
where receptors have not yet been identified, such as membrane traffic
(11, 23) or complex cellular responses, including cell differentiation
(24).
The antigenic site recognized by antibody K-20 encompasses the distal
end of helix A and the beginning of the following loop, a region of
general sequence diversity among G
-subunits that is freely
accessible and seems to be poorly ordered in crystals of
G
s-GTP
S (25). Interestingly, in G
i2,
an adjacent region, e.g. the helix B-helix C segment,
undergoes substantial structural changes upon GTP hydrolysis resulting
in an opening of the nucleotide binding pocket (26). However, current
modeling suggests that the antigenic site recognized by K-20 may be too
distant from the plasma membrane (>35 Å) to be involved in direct
physical contact with activated
-adrenergic receptors (5, 6),
raising the interesting possibility that helix A and the beginning of the following loop may be utilized for a receptor-independent activation of Gs. Indeed, it is well established that the
activity of G proteins may be directly modulated by a diverse group of proteins, including terminal complement complexes (13), presenilin (15), neuromodulin (11), tubulin (27), caveolins (28, 29), not yet
identified proteins (12), or amphiphilic small molecular weight
compounds, such as mastoporans (10), carbolins (30), and taste
substances (14). Surprisingly, the peptide corresponding to the
antigenic site of K-20 (residues 100-119) not only neutralized the
action of the antibody but impaired
-adrenergic receptor signaling
via both component subunits of Gs as well, which resulted
in inhibition of all effects of isoproterenol tested, including its
antagonistic effects on adenylyl cyclase and
NADPH-dependent H2O2 generation.
Peptides that are effective in blocking receptor-G protein interaction
are believed to mimic interfacial contact sites between the proteins.
Indeed, this latter type of peptide competition now serves as a
standard approach to identifying protein interaction pairs and their
recognition sequences (31). Although provocative, it therefore appears
safe to conclude that peptide 100-119 competed with G
s
for activated
-adrenergic receptors, implying that the epitope
recognized by antibody K-20 within the
-helical domain is directly
accessible for this class of heptahelical receptors. Consistently, the
peptide did not influence the stimulatory effect of forskolin which
activates adenylyl cyclase directly.
As pointed out above, the conclusion that peptide 100-119 competed
with G
s for activated
-adrenergic receptors implies
that current ideas regarding the orientation of heterotrimeric
Gs relative to the membrane and/or receptors may require
careful reevaluation (1, 2, 4, 6). Much current thinking is based on
the idea of freely mobile receptors, G proteins, and effectors (1-6). Based on this concept, current models predict that the heterotrimer face that interacts with receptors comprises the NH2 and
COOH termini of G
, exposed residues on helix
5 and
strand
6, as well as the COOH terminus of the
-subunit and the sixth or seventh WD repeat of G
. The
-helical
domain is thought to form the cytosolic pole of G
(1, 2, 4-6).
However, heterotrimeric G proteins are enriched in highly organized
vesicular invaginations of the plasma membrane termed caveolae, which
may represent sites of assembly of a signal transducing complex that
could include receptors, G proteins, effectors, and even intracellular
targets of the second messengers generated (28, 29). It has been
reported that G proteins bind to chief structural proteins of these
organelles, the caveolins, via a sequence that lies between the
switch-I and switch-II regions of the
-subunit (28, 29). An
incorporation of this latter site into structural models of the
receptor/G protein complex changes the predicted orientation of the G
protein in a way that brings the
-helical domain in close proximity
to the membrane, which is consistent with the present data predicting a
direct contact of activated
-adrenergic receptors with the distal
end of helix A and the beginning of the following loop.
Overall, it thus appears that antibody K-20 defines an as yet
unrecognized contact site for
-adrenergic receptors on
G
s that localizes to the
-helical domain. This latter
segment is the first example of a receptor binding region outside the
core GTPase domain of G
and is essential for eliciting the responses transmitted by both G
s and G
s.
As yet, the most precisely defined site of receptor contact involves
the extreme carboxyl terminus, which is thought to be of fundamental
importance for receptor recognition and G protein activation (1-6,
32-35). Indeed, COOH-terminal anti-G
s and the peptide
corresponding to its target sequence were as efficacious as peptide
100-119 in blocking the isoproterenol-induced stimulation of adenylyl
cyclase, indicating that the extreme carboxyl terminus is in fact
necessary for
-adrenergic receptor signaling via G
s. However, in contrast to peptide 100-119, COOH-terminal
anti-G
s failed to prevent the isoproterenol-induced
suppression of NADPH-dependent H2O2
generation, a G
s-mediated response. Thus, a contact
of activated
-adrenergic receptors with the extreme carboxyl
terminus of G
s appears to be required solely for
receptor signaling via G
s but is apparently not critical
for receptor recognition and dissociation of the Gs
heterotrimer. The latter finding is difficult to reconcile with current
models of G protein activation but is consistent with the observations
of others, indicating that COOH-terminal G
s antibodies
act as reliable and specific inhibitors of receptor signaling via
G
-subunits only. By contrast, their effects on G
-mediated
responses are variable and may depend on the G protein, receptors, or
cell type studied. Thus, antibodies directed against the COOH termini
of G
q and G
13 have been shown to block
signaling by m3 muscarinic and AT1A angiotensin
II receptors via both types of component subunits of Gq and
G13, while anti- G
i1, and
anti-G
o, or anti-G
s had no effect on
G
-mediated responses elicited by sstr 3-somatostatin receptor
stimulation or during transcytosis, respectively (23, 36-38).
Together with the essential role of the epitope recognized by antibody
K-20, the observation that COOH-terminal anti-G
s
selectively impaired
-adrenergic receptor signaling via
G
s without affecting the G
s-mediated
response is consistent with the concept that
-adrenergic receptors
interact with multiple sites on G
s, each playing a
distinct role, as has also been proposed by others (39). More
importantly, this latter finding implies that the activation and/or
release of G
s by ligand-occupied
-adrenergic
receptors may not require the simultaneous activation of
G
s, which is in marked contrast to current concepts of G
protein regulation. A subunit-specific activation of a G protein has in
fact been described for the insulin-like growth factor II receptor,
which may selectively turn on G
2-mediated pathways
(40). However, this latter type of selectivity is achieved through
sequestration of free 
-subunits by the activated receptors, which
is not comparable with the mechanism outlined above. Whether receptors
exist that selectively activate G
without affecting the function of
G
or vice versa remains to be established.
In conclusion, the current findings show that a commercially available
polyclonal antiserum directed against residues 100-119 within the
-helical domain of G
s (K-20) acts as a
-adrenergic receptor-mimetic agent, and defines a novel contact site for activated
-adrenergic receptors that localizes to the
-helical domain. In
contrast to the COOH terminus of G
s, which seems to be
critical for
-adrenergic receptor signaling via G
s
only, the epitope recognized by antibody K-20 appears to be essential
for eliciting the complete spectrum of
-adrenergic responses
mediated by both G
s as well as G
s.
| |
ACKNOWLEDGEMENT |
|---|
We are indebted to Brigitte Sattel for expert technical assistance.
| |
FOOTNOTES |
|---|
* This work was supported by a grant from the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
2 H. I. Krieger-Brauer, B. Sattel, P. Medda, and H. Kather, submitted for publication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
MES, 2-(N-morpholino)ethanesulfonic acid;
GTP
S, guanosine-5'-O-(3-thiotriphosphate);
MOPS, 3-(N-morpholino)propanesulfonic acid;
AMP(PNP), adenylyl
imidodiphosphate;
PBS, phosphate-buffered saline;
CTX, cholera
toxin;
NEM, N-ethylmaleimide.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Neer, E. J. (1995) Cell 80, 249-257[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Hamm, H. E., and Gilchrist, A. (1996) Curr. Opin. Cell Biol. 8, 189-196[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Rodbell, M. (1997) Adv. Enzyme Regal. 37, 427-435[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Neubig, R. R. (1994) FASEB J. 8, 939-946[Abstract] |
| 5. | Bohm, A., Gaudet, R., and Sigler, P. B. (1997) Curr. Opin. Biotechnol. 8, 480-487[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Iiri, T., Farfel, Z., and Bourne, H. R. (1998) Nature 394, 35-38[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Osawa, S., Dhanasekaran, N., Woon, C. W., and Johnson, G. L. (1990) Cell 63, 697-708[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Markby, D. W.,
Onrust, R.,
and Bourne, H. R.
(1993)
Science
262,
1895-1901 |
| 9. |
Lin, W.,
and Northup, J. K.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12878-12883 |
| 10. |
Higashijima, T.,
Uzu, S.,
Nakajima, T.,
and Ross, F. M.
(1988)
J. Biol. Chem.
263,
6491-6494 |
| 11. |
Vitale, N.,
Deloulme, J. C.,
Thierse, D.,
Aunis, D.,
and Bader, M. F.
(1994)
J. Biol. Chem.
269,
30293-30298 |
| 12. |
Sato, M.,
Ribas, C.,
Hildebrandt, J. D.,
and Lanier, S. M.
(1996)
J. Biol. Chem.
271,
30052-30060 |
| 13. |
Niculescu, F.,
Rus, H.,
and Shin, M. L.
(1994)
J. Biol. Chem.
269,
4417-4423 |
| 14. | Naim, M., Seifert, R., Nürnberg, B., Grünbaum, L., and Schultz, G. (1994) Biochem. J. 297, 451-454 |
| 15. |
Smine, A.,
Xu, X.,
Nishiyama, K.,
Katada, T.,
Gambetti, P.,
Yadaw, S. P.,
Wu, X.,
Shi, Y.-C.,
Yasuhara, S.,
Homburger, V.,
and Okamoto, T.
(1998)
J. Biol. Chem.
273,
16281-16288 |
| 16. |
Krieger-Brauer, H. I.,
Medda, P. K.,
and Kather, H.
(1997)
J. Biol. Chem.
272,
10135-10143 |
| 17. | Togoshige, M., Okuga, S., and Rebois, R. V. (1994) Biochemistry 33, 4865-4871[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Togoshige, M.,
Basi, N. S.,
and Rebois, R. V.
(1996)
J. Biol. Chem.
271,
8791-8795 |
| 19. | Cassel, D., and Selinger, Z. (1976) Biochim. Biophys. Acta 452, 538-551[Medline] [Order article via Infotrieve] |
| 20. | Jakobs, K. H., and Aktories, K. (1988) Biochem. J. 249, 639-643[Medline] [Order article via Infotrieve] |
| 21. |
Taussig, R.,
Tang, W. J.,
Hepler, J. R.,
and Gilmann, A. G.
(1994)
J. Biol. Chem.
269,
6093-6100 |
| 22. | Yilla, M., Oleinick, J., and Ploegh, H. L. (1996) FEBS Lett. 387, 16-22[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Bomsel, M.,
and Mostov, K. E.
(1993)
J. Biol. Chem.
268,
25824-25835 |
| 24. | Wang, H. Y., Watkins, D. C., and Malbon, C. C. (1992) Nature 358, 334-337[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Sunahara, R. K.,
Tesmer, J. J. G.,
Gilman, A. G.,
and Sprang, S. R.
(1997)
Science
278,
1943-1947 |
| 26. |
Mixon, M. B.,
Lee, E.,
Coleman, D. E.,
Berghuis, A. M.,
Gilman, A. G.,
and Sprang, S. R.
(1995)
Science
270,
954-960 |
| 27. | Roychowdhury, S., and Rasenick, M. M. (1994) Biochemistry 33, 9800-9805[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Li, S.,
Okamoto, T.,
Chun, M.,
Sargiacomo, M.,
Casanova, J. F.,
Hansen, S. H.,
Nishimoto, J.,
and Lisanti, M. P.
(1995)
J. Biol. Chem.
270,
15693-15701 |
| 29. |
Couet, J.,
Li, S.,
Okamoto, T.,
Ikezu, T.,
and Lisanti, M. P.
(1997)
J. Biol. Chem.
272,
6525-6533 |
| 30. | Klinker, J. F., Seifert, R., Damm, H., and Rommelspacher, H. (1997) Biochem. Pharmacol. 53, 1621-1626[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Taylor, J. M., and Neubig, R. R. (1994) Cell. Signalling 6, 841-849[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Simonds, W. F.,
Goldschmidt, P. K.,
Codina, J.,
Unson, C. G.,
and Spiegel, A. M.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
7809-7813 |
| 33. |
Masters, S. B.,
Sullivan, K. A.,
Miller, R. T.,
Beiderrman, B.,
Lopez, N. G.,
Ramachandran, J.,
and Bourne, H. R.
(1988)
Science
241,
448-451 |
| 34. | Liu, J., Conklin, B. R., Blin, N., Yun, J., and Wess, J. (1995) Proc. Natl. Acad. Sci. U. S. A. 95, 11642-11646 |
| 35. | Conklin, B. R., Farfel, Z., Lustig, K. D., Julius, D., and Bourne, H. R. (1993) Nature 363, 274-276[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Stehno-Bittel, L.,
Krapivinsky, P.,
Krapivinsky, L.,
Perez-Terzic, C.,
and Clapham, D. E.
(1995)
J. Biol. Chem.
270,
30068-30074 |
| 37. |
Macrez, N.,
Morel, J.-L.,
Kalkbrenner, K.,
Viard, P.,
Schultz, G.,
and Mironneau, J.
(1997)
J. Biol. Chem.
272,
23180-23185 |
| 38. |
Murthy, K. S.,
Coy, D. H.,
and Makhlouf, G. M.
(1996)
J. Biol. Chem.
271,
23458-23463 |
| 39. |
Skiba, N. P.,
and Hamm, H. E.
(1996)
J. Biol. Chem.
271,
413-424 |
| 40. |
Ikezu, T.,
Okamoto, T.,
Giambarella, U.,
Yokota, T.,
and Nishimoto, J.
(1995)
J. Biol. Chem.
270,
29224-29228 |
This article has been cited by other articles:
![]() |
J. E. Slessareva, H. Ma, K. M. Depree, L. A. Flood, H. Bae, T. M. Cabrera-Vera, H. E. Hamm, and S. G. Graber Closely Related G-protein-coupled Receptors Use Multiple and Distinct Domains on G-protein {alpha}-Subunits for Selective Coupling J. Biol. Chem., December 12, 2003; 278(50): 50530 - 50536. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Krieger-Brauer, P. K. Medda, B. Sattel, and H. Kather Inhibitory Effect of Isoproterenol on NADPH-dependent H2O2 Generation in Human Adipocyte Plasma Membranes Is Mediated by beta gamma -Subunits Derived from Gs J. Biol. Chem., January 28, 2000; 275(4): 2486 - 2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Krieger-Brauer, P. Medda, and H. Kather Basic Fibroblast Growth Factor Utilizes Both Types of Component Subunits of Gs for Dual Signaling in Human Adipocytes. STIMULATION OF ADENYLYL CYCLASE VIA Galpha s AND INHIBITION OF NADPH OXIDASE BY Gbeta gamma s J. Biol. Chem., November 10, 2000; 275(46): 35920 - 35925. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||